Masaya Okada Selected Research

Masaya Okada Research Topics

Disease

18	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 08/2005
9	Infections 12/2015 - 10/2002
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 04/2009
7	Leukemia 01/2014 - 07/2007
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 05/2002
6	Hematologic Neoplasms (Hematological Malignancy) 03/2021 - 01/2005
5	Philadelphia Chromosome 01/2015 - 04/2009
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013 - 04/2009
4	Disease Progression 12/2015 - 12/2010
4	Acute Promyelocytic Leukemia 10/2013 - 01/2002
4	Thrombotic Microangiopathies 09/2006 - 10/2004
3	Bronchiolitis Obliterans Syndrome 11/2023 - 09/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2023 - 01/2002
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021 - 10/2009
3	Lymphoma (Lymphomas) 07/2019 - 12/2012
3	Neoplasms (Cancer) 07/2019 - 05/2013
3	Pneumonia (Pneumonitis) 08/2012 - 05/2002
3	Thrombotic Thrombocytopenic Purpura 04/2006 - 10/2004
2	Hemorrhage 11/2023 - 03/2007
2	Residual Neoplasm 12/2021 - 01/2016
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2020 - 10/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2016 - 12/2002
2	Wilms Tumor (Wilm's Tumor) 03/2016 - 01/2016
2	Spinal Cord Diseases 01/2014 - 10/2013
2	Viremia 08/2012 - 05/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2024
1	Multiple Myeloma 12/2021
1	Peritonitis 10/2021
1	Carcinogenesis 03/2016
1	Bruton type agammaglobulinemia 02/2016
1	Hepatitis B 12/2015
1	Liver Failure 12/2015
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2015
1	Disseminated Intravascular Coagulation 01/2014
1	Epstein-Barr Virus Infections 01/2014

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 04/2009
5	SteroidsIBA 02/2024 - 08/2011
5	Methylprednisolone FDA LinkGeneric 01/2021 - 05/2002
5	Dasatinib (BMS 354825)FDA Link 01/2018 - 04/2009
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014 - 03/2007
5	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2013 - 08/2008
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 08/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019 - 01/2006
4	HLA Antigens (Human Leukocyte Antigens)IBA 10/2015 - 10/2002
4	nilotinib FDA Link 01/2015 - 06/2009
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2022 - 06/2019
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 09/2008
3	fludarabineIBA 08/2015 - 01/2006
3	thiamine triphosphorate (TTP)IBA 04/2006 - 10/2004
2	eculizumab FDA Link 10/2020 - 10/2011
2	Messenger RNA (mRNA)IBA 03/2016 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2013 - 08/2008
2	Cidofovir (Vistide)FDA Link 02/2013 - 08/2012
2	Tyrosine Kinase InhibitorsIBA 04/2012 - 12/2010
2	AntigensIBA 09/2008 - 08/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2008 - 01/2006
2	Methotrexate (Mexate)FDA LinkGeneric 08/2008 - 01/2006
2	CytokinesIBA 08/2005 - 10/2002
1	GlucocorticoidsIBA 02/2024
1	Protein Kinases (Protein Kinase)IBA 01/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2024
1	ibritumomab tiuxetan (Zevalin)FDA Link 05/2023
1	Yttrium-90IBA 05/2023
1	Chelating AgentsIBA 05/2023
1	Radioisotopes (Radionuclides)IBA 05/2023
1	Lenalidomide (CC 5013)FDA Link 12/2021
1	ibrutinibIBA 10/2021
1	ravulizumabIBA 10/2020
1	Complement Inactivating AgentsIBA 10/2020
1	Rituximab (Mabthera)FDA Link 09/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019
1	Prednisone (Sone)FDA LinkGeneric 09/2019
1	Vincristine (Oncovin)FDA LinkGeneric 09/2019
1	DNA (Deoxyribonucleic Acid)IBA 06/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2019
1	Monoclonal AntibodiesIBA 12/2015
1	Antiviral Agents (Antivirals)IBA 12/2015
1	CCR4 ReceptorsIBA 12/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2015
1	entecavir FDA Link 12/2015
1	mogamulizumabIBA 12/2015
1	Busulfan (Busulfex)FDA Link 08/2015
1	bosutinibIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 04/2014
1	CD56 AntigenIBA 01/2014
1	nelarabine (506U78)FDA Link 10/2013

Therapy/Procedure

15	Transplantation 03/2021 - 08/2003
14	Stem Cell Transplantation 11/2023 - 08/2003
10	Hematopoietic Stem Cell Transplantation 08/2022 - 01/2005
10	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 05/2002
8	Therapeutics 12/2021 - 06/2005
5	Drug Therapy (Chemotherapy) 12/2015 - 07/2007
3	Haploidentical Transplantation 02/2024 - 12/2012
2	Radioimmunotherapy 05/2023 - 07/2019
2	Remission Induction 03/2010 - 03/2007
1	Cell Transplantation 02/2024
1	Drug Tapering 11/2023
1	Autologous Transplantation 12/2021
1	Aftercare (After-Treatment) 12/2015